Immune Checkpoint Inhibitors: Altering the Landscape of Treatment in Hepatobiliary Cancers

Download All
Gain insight into the emerging use of immunotherapy in the treatment of hepatobiliary cancers, including HCC and BTCs, with an expert-presented webcast and downloadable slidesets.
Lipika Goyal, MD
R. Kate Kelley, MD
Amit G. Singal, MD, MS

On-Demand Webcast

In this interactive recording of a live CCO webinar, experts discuss current best practices and emerging strategies for using immune checkpoint inhibitors to treat patients with hepatobiliary cancers.

Lipika Goyal, MD R. Kate Kelley, MD Amit G. Singal, MD, MS Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: July 27, 2021 Expired: July 26, 2022

Downloadable Slidesets

Download this slideset for expert perspectives on best practices and emerging strategies in using immune checkpoint inhibitors for patients with advanced hepatocellular carcinoma.

Lipika Goyal, MD R. Kate Kelley, MD Amit G. Singal, MD, MS Released: June 17, 2021

Download this slideset for expert perspectives on emerging strategies in using immune checkpoint inhibitors for patients with early- and intermediate-stage hepatocellular carcinoma and advanced biliary tract cancers.

Lipika Goyal, MD R. Kate Kelley, MD Amit G. Singal, MD, MS Released: June 17, 2021

Download this short summary slideset of key takeaway points on using immune checkpoint inhibitors for patients with hepatocellular carcinoma and biliary tract cancers.

Lipika Goyal, MD R. Kate Kelley, MD Amit G. Singal, MD, MS Released: June 18, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AstraZeneca

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue